Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $11.7K | $123.6K | $171.2K | $271.0K |
| Cost of revenue | $0 | $0 | $0 | $0 | $7.6K | $51.8K | $77.9K | $49.1K |
| Gross profit | $0 | $0 | $0 | $0 | $4.1K | $71.8K | $93.3K | $221.9K |
| Gross margin | — | — | — | — | 34.8% | 58.1% | 54.5% | 81.9% |
| R&D | $60.2K | $57.3K | $48.1K | $56.5K | $263.6K | $183.0K | $229.7K | $186.0K |
| Operating income | −$605.2K | −$461.3K | −$403.6K | −$634.0K | −$604.7K | −$446.6K | −$394.9K | −$179.9K |
| EBITDA | −$574.7K | −$445.9K | −$420.2K | −$636.5K | −$601.3K | −$282.7K | −$367.4K | −$166.0K |
| Net income | −$862.9K | −$724.7K | −$691.6K | −$953.3K | −$948.8K | −$672.0K | −$729.4K | −$515.5K |
| Net margin | — | — | — | — | -8139.5% | -543.7% | -426.1% | -190.2% |
| EPS (diluted) | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Annual figures · source: Financial Modeling Prep
ADVANCED BIOMEDICAL TECHS
No one on the platform currently holds ABMT.
No tracked institution reports a position in ABMT as of their last filing.
No one on the platform has traded ABMT yet.
| +0.00% |
| $18443 |
| — |
| MDXLMedixall Group, Inc. | $0.01 | +0.00% | $1M | — |
| MRRCFWayland Group Corp. | $0.00 | +0.00% | $2121 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.